Matches in Wikidata for { <http://www.wikidata.org/entity/Q74267634> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q74267634 description "article scientifique publié en 1998" @default.
- Q74267634 description "artikull shkencor i botuar më 01 shkurt 1998" @default.
- Q74267634 description "artículu científicu espublizáu en febreru de 1998" @default.
- Q74267634 description "im Februar 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74267634 description "scientific article published on 01 February 1998" @default.
- Q74267634 description "wetenschappelijk artikel" @default.
- Q74267634 description "наукова стаття, опублікована в лютому 1998" @default.
- Q74267634 name "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 name "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 name "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 type Item @default.
- Q74267634 label "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 label "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 label "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 prefLabel "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 prefLabel "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 prefLabel "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 P1433 Q74267634-9DD7170A-4AED-451E-BD41-AB8367029956 @default.
- Q74267634 P1476 Q74267634-FFBFEE88-6428-4EDA-9228-A7E97C5EA604 @default.
- Q74267634 P2093 Q74267634-03EBFE6E-5E5B-45DC-8E7C-B6F09F81088D @default.
- Q74267634 P2093 Q74267634-3CFD2A7F-9D16-4CFC-9400-11E2AE5768B7 @default.
- Q74267634 P2093 Q74267634-7FE5E7C1-EB43-491A-A373-35BB67FAA020 @default.
- Q74267634 P2093 Q74267634-E36B2F70-EAC1-4C31-9E54-0042DB350ECE @default.
- Q74267634 P2093 Q74267634-E5B1F653-EB1C-494D-8DC7-02F2D8E39D43 @default.
- Q74267634 P2093 Q74267634-E5DB3F75-CEEF-4AAE-B8B7-EE6F7AD6D51B @default.
- Q74267634 P2093 Q74267634-FD47EBE1-D793-4151-A967-415D5126182F @default.
- Q74267634 P2860 Q74267634-08EB09A0-4019-4C3E-95E2-EF706AD7397F @default.
- Q74267634 P2860 Q74267634-2EFD3EF8-BA6F-402C-BE9C-DFB6B066B756 @default.
- Q74267634 P2860 Q74267634-38881352-D9E4-4BB1-8585-A9B9CF39A507 @default.
- Q74267634 P2860 Q74267634-6E284B42-DACC-4EC2-9B42-187BD711B959 @default.
- Q74267634 P2860 Q74267634-965E5301-583E-4068-A30B-478733233BDD @default.
- Q74267634 P2860 Q74267634-98CF96A3-9745-4283-9D96-B429E322446C @default.
- Q74267634 P2860 Q74267634-9DA9C77C-B569-44E5-85E4-B6D977BA4756 @default.
- Q74267634 P2860 Q74267634-A12FF45F-1A6D-4BC3-9855-E9C23C5CC32A @default.
- Q74267634 P2860 Q74267634-AE2DB03C-D0E9-4AE5-8657-921DB34E55DA @default.
- Q74267634 P2860 Q74267634-D5A5A454-69EB-4B98-B7F4-98E22E7E4C4F @default.
- Q74267634 P2860 Q74267634-ECC0A614-1868-49CD-AECC-044B6CB018E8 @default.
- Q74267634 P304 Q74267634-A1145666-8920-4424-99C7-84FE54A6155E @default.
- Q74267634 P31 Q74267634-B30EDD90-7A54-488B-836F-BD4054E6B5E3 @default.
- Q74267634 P356 Q74267634-40679F46-F76C-4C35-AF4F-5DF0A2677514 @default.
- Q74267634 P407 Q74267634-32E3FF6C-996C-4958-850C-0A3E6AE2D653 @default.
- Q74267634 P433 Q74267634-6B0BEBB1-FC3A-43D6-9657-AE45F789AA90 @default.
- Q74267634 P478 Q74267634-8ACD7C82-6DB4-4A9D-B97C-35733ECC9CF6 @default.
- Q74267634 P577 Q74267634-C07FE887-FC6F-4914-9394-6B93920E9034 @default.
- Q74267634 P698 Q74267634-FF9150B9-5A48-42E7-87E8-0F5098B47DCA @default.
- Q74267634 P921 Q74267634-2A313789-9429-40E3-BACB-69ED33135D42 @default.
- Q74267634 P356 S0002-8703(98)70087-0 @default.
- Q74267634 P698 9489970 @default.
- Q74267634 P1433 Q2227156 @default.
- Q74267634 P1476 "Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure" @default.
- Q74267634 P2093 "A Hamer" @default.
- Q74267634 P2093 "B Jackson" @default.
- Q74267634 P2093 "D Hare" @default.
- Q74267634 P2093 "H Krum" @default.
- Q74267634 P2093 "J Karrasch" @default.
- Q74267634 P2093 "L G Howes" @default.
- Q74267634 P2093 "P Leslie" @default.
- Q74267634 P2860 Q33614305 @default.
- Q74267634 P2860 Q34682919 @default.
- Q74267634 P2860 Q37680015 @default.
- Q74267634 P2860 Q43472007 @default.
- Q74267634 P2860 Q44074545 @default.
- Q74267634 P2860 Q53625496 @default.
- Q74267634 P2860 Q54446574 @default.
- Q74267634 P2860 Q67486514 @default.
- Q74267634 P2860 Q69584556 @default.
- Q74267634 P2860 Q70623796 @default.
- Q74267634 P2860 Q71401325 @default.
- Q74267634 P304 "237-241" @default.
- Q74267634 P31 Q13442814 @default.
- Q74267634 P356 "10.1016/S0002-8703(98)70087-0" @default.
- Q74267634 P407 Q1860 @default.
- Q74267634 P433 "2 Pt 1" @default.
- Q74267634 P478 "135" @default.
- Q74267634 P577 "1998-02-01T00:00:00Z" @default.
- Q74267634 P698 "9489970" @default.
- Q74267634 P921 Q11829287 @default.